| Old Articles: <Older 1741-1750 Newer> |
 |
The Motley Fool February 2, 2005 Brian Gorman |
Pfizer's Troubling Trust Issue The company is in danger of losing the public's confidence.  |
The Motley Fool February 2, 2005 Rich Duprey |
Aastrom to Leap Into Trials The biotech firm advances to the next stage of clinical studies in stem cell research. Investors, take note.  |
Registered Rep. February 1, 2005 Bob Hirschfeld |
Healing Investments New lung cancer drugs mean good news in both the doctor's office and on Wall Street.  |
The Motley Fool February 1, 2005 Stephen D. Simpson |
Stent Maker's Hearty Returns Medical device company Boston Scientific rebounds from cardiac stent recall with strong growth.  |
The Motley Fool February 1, 2005 Stephen D. Simpson |
Zimmer Shoots From the Hip Pure-play orthopedic company delivers the goods, but at what cost? Zimmer carries a price tag that would make a value investor's bones ache.  |
Inc. February 2005 Patrick J. Sauer |
The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan.  |
Managed Care January 2005 Alice G. Gosfield |
P4P: Transitional at Best Pay-for-performance (P4P) programs promise a fair shake for provider and insurance plan, but a former chairman of the National Committee for Quality Assurance sees many design flaws to overcome.  |
Managed Care January 2005 |
Is It Time To Create a 'Fed Board' To Oversee Clinical Research? The physician-author of "Overdosed America" argues that the privatization of medical research, the diminished role of universities as impartial overseers of medical knowledge, and the drug and medical-device industry's growing influence on government have changed the fundamental purpose of medical knowledge in the United States.  |
Managed Care January 2005 John A. Marcille |
You Don't Need X-Ray Vision To Spot a Job Well Done If the White House indeed takes on tort reform this year, it will be interesting to see if any meaningful legislation results and what effect it might have on health care.  |
Managed Care January 2005 John Carroll |
Government's EMR Project Yet To Net Seed Money The $50 million needed for regional collaborations was not part of the federal government's budget. Not the end of the world, but not good either.  |
| <Older 1741-1750 Newer> Return to current articles. |